PL2105129T3 - Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt - Google Patents

Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt

Info

Publication number
PL2105129T3
PL2105129T3 PL09156077T PL09156077T PL2105129T3 PL 2105129 T3 PL2105129 T3 PL 2105129T3 PL 09156077 T PL09156077 T PL 09156077T PL 09156077 T PL09156077 T PL 09156077T PL 2105129 T3 PL2105129 T3 PL 2105129T3
Authority
PL
Poland
Prior art keywords
boostering
fish
animals
oral vaccination
encapsulated vaccines
Prior art date
Application number
PL09156077T
Other languages
English (en)
Polish (pl)
Inventor
Moti Harel
Original Assignee
Intervet International B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International B.V. filed Critical Intervet International B.V.
Publication of PL2105129T3 publication Critical patent/PL2105129T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/80Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0233Rickettsiales, e.g. Anaplasma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0275Salmonella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55583Polysaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
PL09156077T 2008-03-24 2009-03-24 Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt PL2105129T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3880908P 2008-03-24 2008-03-24
EP09156077.1A EP2105129B1 (en) 2008-03-24 2009-03-24 Encapsulated Vaccines for the Oral Vaccination and Boostering of Fish and Other Animals

Publications (1)

Publication Number Publication Date
PL2105129T3 true PL2105129T3 (pl) 2018-04-30

Family

ID=40707755

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09156077T PL2105129T3 (pl) 2008-03-24 2009-03-24 Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt

Country Status (6)

Country Link
US (2) US7998502B2 (en:Method)
EP (1) EP2105129B1 (en:Method)
CA (1) CA2659917C (en:Method)
ES (1) ES2661038T3 (en:Method)
NO (1) NO2105129T3 (en:Method)
PL (1) PL2105129T3 (en:Method)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1973406T3 (da) 2005-12-28 2014-06-23 Advanced Bionutrition Corp Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
US8778384B2 (en) 2008-03-24 2014-07-15 Advanced Bionutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
NO2105129T3 (en:Method) * 2008-03-24 2018-06-16
CA2756883C (en) * 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
CN102470106B (zh) 2009-05-18 2015-09-23 希格默伊德药业有限公司 包含油滴的组合物
EP2435554B1 (en) 2009-05-26 2017-07-26 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
BR112012002963A2 (pt) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
US8834951B2 (en) 2010-01-28 2014-09-16 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
AR082682A1 (es) 2010-08-13 2012-12-26 Advanced Bionutrition Corp Composicion estabilizadora de almacenamiento en seco para materiales biologicos
US9345760B2 (en) 2011-09-09 2016-05-24 Advanced Bionutrition Corporation IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same
IN2014DN06743A (en:Method) 2012-02-21 2015-05-22 Advanced Bionutrition Corp
WO2013139393A1 (en) 2012-03-22 2013-09-26 Bioorganic Research And Services Sa Formulations for non-invasive delivery of active proteins to an animal or human
CA2783146C (en) * 2012-05-08 2020-04-07 Advanced Bionutrition Corp. Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
JP6712222B2 (ja) 2013-12-06 2020-06-17 インターベット インターナショナル ベー. フェー. 生物活性剤の経口送達用組成物
AU2015341695B2 (en) 2014-11-07 2021-07-08 Sublimity Therapeutics Limited Compositions comprising cyclosporin
WO2018126026A1 (en) 2016-12-28 2018-07-05 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
AU2016282996A1 (en) 2015-06-25 2018-01-18 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US10632157B2 (en) 2016-04-15 2020-04-28 Ascus Biosciences, Inc. Microbial compositions and methods of use for improving fowl production
JP2018525340A (ja) * 2015-06-26 2018-09-06 アドバンスド バイオニュートリション コープ. 動物に活性剤を送達するための組成物
CA2994112C (en) 2015-07-29 2023-08-08 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
JP7082058B2 (ja) 2016-01-07 2022-06-07 ネイティブ マイクロビアルズ, インコーポレイテッド 微生物共同体の投与により乳生産を改善する方法
CN109874294B (zh) 2016-04-15 2023-06-20 原生微生物股份有限公司 通过施用微生物聚生体或其纯化菌株来提高禽类的农业生产的方法
EP3471705A1 (en) * 2016-06-20 2019-04-24 Virbac Method and apparatus for preparing a micro-particles composition
MX2019007760A (es) 2016-12-28 2020-02-10 Ascus Biosciences Inc Metodos, aparatos y sistemas para analisis de cepa de microorganismo de comunidades heterogeneas complejas con analisis rastreador, determinacion de relaciones funcionales e interacciones de estas, y sintesis de agrupaciones microbianas que incluyen agrupaciones microbianas dosificadas y agrupaciones microbianas inoculativas.
WO2018201049A1 (en) 2017-04-28 2018-11-01 Ascus Biosciences, Inc. Methods for supporting grain intensive and/or energy intensive diets in ruminants with a synthetic bioensemble of microbes
BR112020007707A2 (pt) 2017-10-18 2021-01-26 Ascus Biosciences, Inc. melhoria de produção de ave por administração de um bioconjunto sintético de micróbios ou cepas purificadas dos mesmos
CA3166211A1 (en) 2020-02-10 2021-08-19 Native Microbials, Inc. Microbial compositions and methods of use for canine enteropathy and dysbiosis
CN116083240B (zh) * 2023-04-07 2023-08-29 深圳市第二人民医院(深圳市转化医学研究院) 工程化细菌及其制备方法和应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM572294A0 (en) 1994-05-18 1994-06-09 Vaccine Technologies Pty. Ltd. Delivery vehicle for bioactive molecule
US6485950B1 (en) * 2000-07-14 2002-11-26 Council Of Scientific And Industrial Research Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions
CA2429254A1 (en) * 2000-11-20 2002-05-30 James M. Dunn Oral nanosphere delivery
ATE400189T1 (de) 2001-03-23 2008-07-15 Advanced Bionutrition Corp Abgabe von mitteln zur krankheitskontrolle in aquakultur unter verwendung von bioaktive proteine enthaltender hefe
MXPA04001660A (es) * 2001-08-27 2004-11-22 Advanced Bionutrition Corp Suministro para el control de enfermedad en acuacultura y agricultura usando alimentos nutritivos que contienen proteinas bioactivas producidas por virus.
US7550647B2 (en) * 2001-09-14 2009-06-23 Advanced Bionutrition Transfected shrimp as production systems for therapeutic proteins
WO2003079810A1 (en) * 2002-03-19 2003-10-02 Advanced Bionutrition Corporation Microalgal feeds containing arachidonic acid and their production and use
AU2003224952A1 (en) 2002-04-15 2003-11-03 Thomas F. C. Allnutt Incorporation of anaerobic bacteria in feed formulation
AU2003229667A1 (en) * 2002-04-18 2003-10-27 Akzo Nobel N.V. Antigen-loaded chitosan microparticles for oral vaccination
EP1534307A4 (en) * 2002-06-11 2007-09-05 Advanced Bionutrition Corp ZOOPLANKTON ENRICHMENT WITH PROBIONS AND PREBIONS AND THEIR USE
US20060121468A1 (en) * 2002-06-26 2006-06-08 Allnutt F C T Viruses and virus-like particles for multiple antigen and target display
AU2003270652A1 (en) * 2002-09-16 2004-04-30 Advanced Bionutrition Corporation Protein and peptide expression for passive immunity
AU2003279819A1 (en) * 2002-10-24 2004-05-13 Advanced Bionutrition Corporation Shrimp and the production thereof
NZ539900A (en) * 2002-11-07 2008-03-28 Advanced Bionutrition Corp Nutraceuticals and method of feeding aquatic animals
WO2004043139A2 (en) 2002-11-14 2004-05-27 Advanced Bionutrition Corp. Feed suitable for culturing rotifers, larval shrimp, and marine filter feeders
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
WO2004080196A2 (en) * 2003-03-07 2004-09-23 Advanced Bionutrition Corporation Feed formulation for terrestrial and aquatic animals
WO2005017134A2 (en) * 2003-08-19 2005-02-24 Council Of Scientific And Industrial Research Isozyme of autoclavable superoxide dismutase (sod) derived from curcuma longa l
US20080194504A1 (en) * 2004-02-06 2008-08-14 Advanced Bionutrition Corporation Rna-Mediated Interference to Control Disease in Terrestrial and Aquaculture Animals
US20040224019A1 (en) * 2004-03-03 2004-11-11 Adi Shefer Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs
US7973148B2 (en) * 2004-04-15 2011-07-05 Advanced Bionutrition Corporation Crustacean expression vector
EP1750674A4 (en) * 2004-05-27 2012-05-23 Advanced Bionutrition Corp MICROPARTICLES FOR THE ORAL LEVY
WO2007001448A2 (en) * 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
EP1888055A4 (en) 2005-05-11 2009-10-21 Advanced Bionutrition Corp FISH OIL UNDER STABILIZED FORM
US7956031B2 (en) * 2005-05-31 2011-06-07 Naidu Lp Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
US20080286375A1 (en) * 2005-11-15 2008-11-20 Amorepacific Corporation Method for Preparing Sustained-Release Microparticles Comprising Sucrose Acetate Isobutyrate
WO2007075988A2 (en) * 2005-12-21 2007-07-05 Advanced Bionutrition Corporation Non-invasive detection of fish viruses by real-time pcr
DK1973406T3 (da) * 2005-12-28 2014-06-23 Advanced Bionutrition Corp Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform
US20090238890A1 (en) * 2006-01-13 2009-09-24 Advanced Bionutrition Corporation Continuous spray-capture production system
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
CN101460141A (zh) 2006-04-03 2009-06-17 先进生物营养公司 包含二十二碳六烯酸的饲料制剂
JP2010509363A (ja) * 2006-11-08 2010-03-25 ノババックス,インコーポレイテッド 固体剤形の多相医薬組成物の製造方法
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
CA2673355A1 (en) 2006-12-20 2008-11-20 Advanced Bionutrition Corporation Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast
US20080305096A1 (en) * 2007-06-07 2008-12-11 Unicity International, Inc. Method and composition for providing controlled delivery of biologically active substances
NO2105129T3 (en:Method) * 2008-03-24 2018-06-16
WO2010042555A2 (en) * 2008-10-06 2010-04-15 The Brigham And Women's Hospital, Inc. Particles with multiple functionalized surface domains
ES2732833T3 (es) * 2009-03-26 2019-11-26 Advanced Bionutrition Corp Microencapsulación de sustancias bioactivas y métodos de obtención de la misma
CA2756883C (en) * 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
AR082682A1 (es) * 2010-08-13 2012-12-26 Advanced Bionutrition Corp Composicion estabilizadora de almacenamiento en seco para materiales biologicos

Also Published As

Publication number Publication date
CA2659917C (en) 2012-07-17
US20110293657A1 (en) 2011-12-01
ES2661038T3 (es) 2018-03-27
US8329209B2 (en) 2012-12-11
US7998502B2 (en) 2011-08-16
EP2105129B1 (en) 2018-01-17
NO2105129T3 (en:Method) 2018-06-16
EP2105129A3 (en) 2011-04-27
EP2105129A2 (en) 2009-09-30
US20090238845A1 (en) 2009-09-24
CA2659917A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
PL2105129T3 (pl) Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt
IL194387A0 (en) Methods and compositions for vaccination of poultry
PL2019680T3 (pl) Zwiększenie miana poszczepiennego u zwierząt
ZA200802892B (en) Vaccines and methods to treat canine influenza
SI2461833T1 (sl) Vakcinski sestavek, ki obsega 5'-cap modificirano RNA
EP2244720A4 (en) POLYPEPTIDE VACCINE AND VACCINE STRATEGY AGAINST MYCOBACTERIUM
HUE040019T2 (hu) Hajnövekedést stimuláló készítmények és módszerek
ZA200906387B (en) Compositions and methods for enhancing the development of growing animals
PL2424621T3 (pl) Sposoby poprawy smaku i kompozycji do higieny jamy ustnej o ulepszonym smaku
ZA200904756B (en) Methods of vaccine administration
IL208241A0 (en) Heat shock protein gp96 vaccination and methods of using same
ZA201201714B (en) Protein matrix vaccines of improved immunogenicity
EP2453886A4 (en) PHARMACEUTICAL PRODUCT FOR ORAL ADMINISTRATION COMPRISING MGBG AND METHODS OF TREATING DISEASE
EP2133092A4 (en) Oral vaccine
IL211670A (en) Preparations containing therapeutic antibodies against steap-1
EP2773317A4 (en) COMPOSITIONS FOR IMPROVING THE ORAL HEALTH OF ANIMALS, METHOD FOR THEIR USE AND PET FOOD THEREFOR
ZA201103031B (en) Vaccine against african horse sickness virus
ZA201005149B (en) Method of increasing the milk and/or meat quantity of silage-fed animals
FR2952382B1 (fr) Vaccins et diagnostics contre les trypanosomoses animales africaines
IL198897A0 (en) Canine leishmania vaccine
EP2454374A4 (en) ORAL VACCINES PRODUCED AND ADMINISTERED WITH AN EDIBLE MICROORGANISM
GB2493662B (en) Salmonid alphavirus vaccine
EP2482843A4 (en) PROCESS FOR IMPROVED VACCINE IMMUNOGENICITY
EP2424512A4 (en) METHODS AND COMPOSITIONS FOR IMPROVING ANIMAL HEALTH
GB0811616D0 (en) Dental constructs and methods for their preparation